TriPharm Services, a new contract development and manufacturing organization (CDMO), is commissioning a new specialized manufacturing operation utilizing the latest isolator manufacturing equipment. The center of excellence specializes in injectable pharmaceutical capabilities including flexible manufacturing […]
Verseau Therapeutics, Inc. (“Verseau”) launched with $50 million in financing from 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The Mark Foundation for Cancer Research and Yonghua Capital. In addition, George […]
Incyte Corporation has announced promising results for ruxolitinib in the Novartis-sponsored Phase III trial REACH2 of patients with steroid-refractory acute graft-versus-host disease. Ruxolitinib met its primary endpoint in the trial of superior overall response rate […]
SMi Reports: Agenda and speaker overview of the upcoming 4th Annual 3D Cell Culture Conference 2020, in London. SMi Group is delighted to announce the return of the successful 3D Cell Culture Conference for its […]
SMi Reports: Overview of the workshops for Europe’s only Parallel Trade conference and exhibition taking place in February 2020 in London. SMi’s highly anticipated Parallel Trade Conference is set to return for its 14th year, […]